Category: Patent Litigation
-
Federal Circuit dismisses ParkerVision appeal against Qualcomm: Rule 54(b) does not allow partial final judgment on some claims of one patent
The Federal Circuit has held that a patent is a single cause of action, so judgments on receiver claims cannot be appealed while transmitter claims remain pending. ParkerVision’s 15 years of litigation have returned to Florida.
-
UPC Court of Appeal establishes need for conditional appeals to keep conditional revocation counterclaims alive in ParTec v. Nvidia
While the CoA has granted a motion for Nvidia to reinstate its right to file an appeal in a case against ParTec, it warned that Nvidia should have brought a conditional appeal to keep its conditional revocation counterclaim alive in the event that the CoA reverses a non-infringement finding made by the UPC’s Munich LD…
-
Nvidia sued in Eastern District of Texas by PAE holding data center, networking patents originally owned by Avaya
PulseLink Systems is also enforcing former Avaya patents against Hewlett Packard Enterprise and Zoom.
-
Netlist adds new ITC complaint against Micron, Broadcom, Google, and Nvidia; “intends to rely on… Samsung” to prove domestic industry
After settling with Netlist last month, Samsung agreed to provide “certain information… to use in future ITC actions against third parties”.
-
Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possible
It will not be easy to defend this record patent damages verdict, given not only its outsized amount but also the deficiencies of the record that Apple has already alleged.
-
French consumer rights group urges Disney+ to compensate customers for switching off 4K following InterDigital injunctionsÂ
While Disney+ switched 4K back on again using a workaround in Germany, the streaming giant has not done the same in its other markets, including France.
-
Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuit
Mylan has asked a Delaware court to declare a newly issued Novo Nordisk Wegovy patent invalid and not infringed, opening a new front in their long-running Hatch-Waxman fight over generic semaglutide.
-
EPO board of appeal rejects claim-saving approach to ambiguous amendments
The EPO Board of Appeal has rejected a claim-saving approach to ambiguous amendments in a Philip Morris e-cigarette patent dispute, holding that unresolved ambiguity can broaden a claim and create added-matter problems.Â
-
Federal court dismisses Entresto antitrust suit against Novartis: patent listing in Orange Book was proper
Judge Liman held that the U.S. Patent No. 8,101,659 claims the active ingredients on Entresto’s FDA label, so its Orange Book listing was proper, ending a payor’s antitrust case with prejudice.